342 assets in Glioblastoma

Therapeutic assets addressing Glioblastoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Camustine Glioblastoma	Leland Metheny	P3	BB (68)
Irinotecan Glioblastoma	University of Cincinnati	P3	BB (68)
(+)-Vincristine Glioblastoma	University of Cincinnati	P3	BB (68)
Capecitabine Glioblastoma	Northwell Health	P2	BB (67)
Lomustine Glioblastoma	Telix Pharmaceuticals (Innovations) Pty Limited	P3	BB (67)
Carboplatin Glioblastoma	Sichuan Honghe Biotechnology Co., Ltd.	P3	BB (66)
Cediranib Glioblastoma	M.D. Anderson Cancer Center	P3	BB (66)
Lenvatinib Glioblastoma	Tel Aviv Medical Center	P2	BB (66)
Regorafenib Glioblastoma	Istituto Oncologico Veneto IRCCS	P2/3	BB (66)
Gx-I7 Glioblastoma	Genexine, Inc.	P2	BB (65)
Valaciclovir Glioblastoma	Trogenix ltd	P2	BB (65)
Adriamycin Glioblastoma	Université de Sherbrooke	P2	BB (64)
Av-Gbm-1 Glioblastoma	Aivita Biomedical, Inc.	P3	BB (64)
Etoposide Glioblastoma	Sichuan Honghe Biotechnology Co., Ltd.	P2/3	BB (64)
Cabozantinib Glioblastoma	M.D. Anderson Cancer Center	P2	B (63)
Cyclophosphamide Glioblastoma	Jennifer Leddon	P4	B (63)
Ipilimumab Glioblastoma	University College, London	P3	B (63)
Mercaptopurine Anhydrous Glioblastoma	The First Affiliated Hospital with Nanjing Medical University	P2	B (63)
Nivolumab Glioblastoma	Duke University	P3	B (63)
Paxalisib Glioblastoma	Institute of Cancer Research, United Kingdom	P2/3	B (63)
Atezolizumab Glioblastoma	Centre Hospitalier Universitaire Vaudois	P2	B (62)
Gm-Csf Glioblastoma	University of Florida	P3	B (62)
Ict-107 Glioblastoma	Precision Life Sciences Group	P3	B (62)
Nivestim Glioblastoma	Massachusetts General Hospital	P3	B (62)
Pembrolizumab Glioblastoma	Jennifer Leddon	P4	B (62)
Apocept Glioblastoma	CANbridge Life Sciences Ltd.	P2	B (61)
Dexasone Glioblastoma	City of Hope Medical Center	P2	B (61)
Dianhydrogalactitol Glioblastoma	Global Coalition for Adaptive Research	P2/3	B (61)
Everolimus Glioblastoma	Nationwide Children's Hospital	P2	B (61)
2-HYDROXYOLEIC ACID (SODIUM SALT) Glioblastoma	Laminar Pharmaceuticals	P2/3	B (60)
Cis-Diamminedichloroplatinum Ii Glioblastoma	Sichuan Honghe Biotechnology Co., Ltd.	P2/3	B (60)
Ferumoxytol Glioblastoma	Jonsson Comprehensive Cancer Center	P3	B (60)
Safusidenib Glioblastoma	Nuvation Bio Inc.	P3	B (60)
WP 1066 Glioblastoma	Northwestern University	P2	B (60)
Azeliragon Glioblastoma	Washington University School of Medicine	P2	B (59)
Indoximod Glioblastoma	Theodore S. Johnson	P2	B (59)
Niraparib Glioblastoma	Ivy Brain Tumor Center	P3	B (59)
11.BETA.,13-DIHYDRO-13-(DIMETHYLAMINO)MICHELIOLIDE Glioblastoma	National Neuroscience Institute	P2	B (58)
5-ala Glioblastoma	Alpheus Medical, Inc.	P3	B (58)
azd1390 Glioblastoma	Children's Oncology Group	P2/3	B (58)
Chloroquine Glioblastoma	Maastricht Radiation Oncology	P3	B (58)
Chlorpromazinum Glioblastoma	Mohammed Milhem	P2	B (58)
Dasatinib Glioblastoma	AHS Cancer Control Alberta	P2	B (58)
Disulfiram Glioblastoma	Olympion Medical Center	P2/3	B (58)
Metformin Glioblastoma	Weill Medical College of Cornell University	P2	B (58)
Tinostamustine Glioblastoma	Mundipharma Research Limited	P2/3	B (58)
Trametinib Glioblastoma	National Cancer Institute (NCI)	P4	B (58)
Valganciclovir Glioblastoma	Rznomics, Inc.	P2	B (58)
Veliparib Glioblastoma	National Cancer Institute (NCI)	P2/3	B (58)
Denifanstat Glioblastoma	Ascletis Pharmaceuticals Co., Ltd.	P3	B (57)

Showing 1 to 50 of 342 assets

PreviousPage 1 of 7Next